Statin induces inhibition of triple negative breast cancer (TNBC) cells via PI3K pathway
Authors:
- Hae Hyun JungHJHae Hyun Jung
- Jin Seok AhnJAJin Seok Ahn
- Young-Hyuck ImYIYoung-Hyuck Im
- 1 September 2013
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 439 (2) , 275-279
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- The clonal and mutational evolution spectrum of primary triple-negative breast cancersNature, 2012
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapiesJournal of Clinical Investigation, 2011
- Utilization of Genomic Signatures to Identify Phenotype-Specific DrugsPLOS ONE, 2009
- Triple-Negative Breast Cancer: Clinical Features and Patterns of RecurrenceClinical Cancer Research, 2007
- Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotypeCancer, 2007
- Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast CancerJournal of Clinical Oncology, 2006
- Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer StudyJAMA, 2006
- Repeated observation of breast tumor subtypes in independent gene expression data setsProceedings of the National Academy of Sciences, 2003
- Molecular portraits of human breast tumoursNature, 2000